Introducing our next-generation liquid biopsy test.
Learn more about FoundationOne®Liquid

The Relentless Pursuit of Better CareOptionsInsightsScience

We never give up. We strive to do more for cancer patients - through richer science, deeper insights, and stronger partnerships - providing better cancer care today, and fueling better cancer care tomorrow.

Foundation Medicine is a world-leading molecular insights company, connecting physicians and their patients to the latest cancer treatment approaches and making precision medicine a reality for thousands.

Better Care Today

1

Genomic Testing

Comprehensive Genomic Profiling

Our portfolio of genomic tests is the leading platform for comprehensive genomic profiling. We analyze more than 300 cancer-relevant genes across the four main classes of genomic alterations to help understand the genomic makeup of a patient's tumor.

2

Molecular Insights

Valuable Insights, Actionable Options

We help match each patient’s unique genomic profile to known targeted therapies, immunotherapies and clinical trials and offer decision support services, financial assistance, and technology solutions to help streamline patient care.

Patient Story

Dealing with cancer is not just dealing with the cancer. It’s treating the whole person.

|

Christine Bray, ovarian cancer survivor, shares her journey to remission after obtaining a Foundation Medicine comprehensive genomic profiling test.

Better Care Tomorrow

3

More Than Numbers

Insights, Not Just Information

Our unique knowledgebase, FoundationCore™, is one of the world's largest cancer genomic databases, with more than 200,000 anonymized patient records, designed to help researchers and biopharma companies advance precision medicine, develop new therapies, and design better trials.

4

Supporting Drug Development

The Preferred Partner to BioPharma

We partner with drug developers throughout each stage of drug research and development, from target discovery to commercial launch. Today, we are working with more than 30 biopharma partners to accelerate new biomarker-driven treatments.

Advancing Cancer Care

Each patient’s cancer informs all those cases that will come in the future.

|

Learn more about how we are advancing the field with our FoundationCore-powered data analytics platform, and our groundbreaking 20,000 patient real-world research dataset.

Gaurav Singal, MD, VP Data Products & Strategy

Better Care Together

5

Collective Advances

The Power of Collaboration

By sharing our genomic data, we empower researchers on the front lines to generate new connections and insights. Today, we proudly participate in a number of sharing initiatives to accelerate research efforts.

6

Transforming Cancer Care

Cultivating an Ecosystem of Partners

Every insight we gain towards better cancer care is multiplied by a hyper-connected network of physicians, biopharma, researchers, patient advocacy organizations and world-leading medical centers. Together, we are transforming cancer care.

From the Blog

Expanding Options for More Patients: Introducing FoundationOne®Liquid

|
Tom Civik
Chief Commercial Officer at Foundation Medicine

With a single tissue biopsy and comprehensive genomic profiling (CGP), people diagnosed with cancer have access to more information about their disease than ever before. These insights are rapidly advancing precision medicine and giving patients the chance to find the treatment most likely to benefit their specific disease.

But what about when tissue is not accessible?

Read the Article

Join Us in the Pursuit of Better

Find out more about genomic testing, learn more about us, or read the latest updates from our blog.